{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "import spacy\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "import os\n",
    "import nltk\n",
    "import numpy as np\n",
    "from pattern.text.en import singularize\n",
    "import nltk\n",
    "from nltk.corpus import stopwords\n",
    "stop_words = stopwords.words('english')\n",
    "import pickle\n",
    "from collections import Counter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "1+2"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Getting sentence classifications"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "f = open(\"LitCovid_sent_classification_formatted.sents\", \"r\")\n",
    "sec_class_sents = f.read()\n",
    "f = open(\"LitCovid_sent_classification_formatted.txt\", \"r\")\n",
    "sec_class_txt = f.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "sec_classes = sec_class_sents.split(\"\\n\\n\\n\")\n",
    "sec_pmids = [t.split(\" | \")[0] for t in sec_class_txt.split(\"\\n\")]\n",
    "sections = {}\n",
    "for i in range(len(sec_pmids)):\n",
    "    if sec_pmids[i] != \"\":\n",
    "        sections[sec_pmids[i]] = [(t.split(\"||\")[0], t.split(\"||\")[1]) for t in sec_classes[i].split(\"\\n\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████| 6470/6470 [00:00<00:00, 10648.03it/s]\n"
     ]
    }
   ],
   "source": [
    "split_sections = {}\n",
    "for i in tqdm(range(len(sec_pmids))):\n",
    "    if sec_pmids[i] != \"\":\n",
    "        sect = sections[sec_pmids[i]]\n",
    "        temp_sect = []\n",
    "        for line in sect:\n",
    "            if len(line[1].split()) > 30:\n",
    "                text = line[1].split()\n",
    "#                 print(text)\n",
    "                split_sentences = [' '.join(text[i:i+30]) for i in range(0, len(text),30)]\n",
    "#                 print(split_sentences)\n",
    "                for sent in split_sentences:\n",
    "                    temp_sect.append((line[0], sent))\n",
    "            else:\n",
    "                temp_sect.append(line)\n",
    "        \n",
    "        split_sections[sec_pmids[i]] = temp_sect"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'47.0(38.0-70.3)'"
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "t  = \"They had a median ( interquartile range [ IQR ] ) age of 47.0 ( 38.0-70.3 ) years , and 16 ( 38.1 % ) were men .\".split()\n",
    "age = \"\".join(t[t.index(\"age\")+1:t.index(\"years\")])\n",
    "regex = re.compile('[a-zA-Z]')\n",
    "regex.sub('', age)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[<re.Match object; span=(0, 3), match='age'>,\n",
       " <re.Match object; span=(14, 17), match='age'>]"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(re.finditer(\"age\", \"ages you know ages\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "custom_syns = [['COVID-19', \"SARS-CoV-2\", \"SARS-CoV-2 infection\", \"COVID-19 infection\", \n",
    "  \"coronavirus disease 2019 ( COVID-19 )\", 'Covid-19', 'laboratory-confirmed COVID-19', \n",
    "  \"coronavirus disease 2019\", \"COVID-19 disease\", \"coronavirus disease\", \"SARS-CoV\", \n",
    "  \"COVID-19 positive\", \"SARS-COV-2\", \"SARS-CoV-2 infections\",  \"Covid-19 infection\", \n",
    "  \"COVID-19 infected\", \"COVID-19-positive\", \"SARS-CoV-2 infected\", \"SARS-CoV-2-infected\",\n",
    "  \"2019-nCoV\", \"COVID-19 infections\", \"COVID 19\", \"COVID19\", \"Covid-19 infection\",\n",
    "  \"severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection\", \n",
    "  'coronavirus disease ( COVID-19 )', \"CoV infections\", \"coronavirus\", \"2019-new coronavirus\",\n",
    "  \"SARS-CoV-2 virus\", \"coronavirus infections\"],\n",
    " [\"severe COVID-19\", \"severe and critical COVID-19\", \"severe COVID-19 infection\", \n",
    "  'severe coronavirus disease 2019 ( COVID-19 )',\n",
    "  'severe coronavirus disease 2019 ( COVID-19 )', \n",
    "  'severe acute respiratory syndrome ( SARS )', 'severe and critical COVID-19',\n",
    "  'severe acute respiratory syndrome coronavirus 2',\n",
    "  'critically ill COVID-19', \"severe COVID-19 disease\"],\n",
    " [\"severe COVID-19 pneumonia\", \"severe pneumonia\", \"COVID-19 pneumonia\", \"SARS-CoV-2 pneumonia\",\n",
    "  'novel coronavirus pneumonia', \"2019-nCoV pneumonia\"],\n",
    " [\"male\", \"men\", \"males\", \"male sex\"],\n",
    " [\"infection\", \"infected\"],\n",
    " [\"female\", \"women\", \"females\", \"female sex\"],\n",
    " [\"child\", \"children\"],\n",
    " [\"severe\", \"severe disease\", \"severity\", \"severe cases\", \"severely ill\", \"severe illness\"],\n",
    " [\"critical\", \"critically ill\",  \"critical illness\"],\n",
    " [\"comorbidity\", \"comorbidities\"],\n",
    " [\"ICU\", \"intensive care unit ( ICU )\", \"intensive care\"],\n",
    " [\"diabetes\", \"diabetes mellitus\", \"diabetic\"],\n",
    " [\"elderly\", \"older age\", \"older adults\", \"older\"],\n",
    " [\"hydroxychloroquine\", \"chloroquine\", \"hcq\"],\n",
    " [\"dead\", \"deceased\", \"mortality\", \"died\", \"death\"]]\n",
    "\n",
    "severe_subtags = [\n",
    "    [\"infection\", \"infections\", \"cases\", \"case\", \"outcomes\", \"outcome\", \"disease\", \"patient\", \"patients\", \"group\"],\n",
    "    [\"pneumonia\", \"event\", \"events\", \"complications\", \"complication\", \"diabetes\", \"disease\"],\n",
    "    [\"fever\", \"acute\", \"ards\", \"acidosis\", \"hypercoagulability\", \"inflammatory\", \"inflammation\"],\n",
    "    [\"course\", \"courses\", \"stages\", \"stage\"]]\n",
    "\n",
    "severe_subtags_names = [\"COVID-19\", \"other diseases\", \"symptoms\", \"course\"]\n",
    "age_subtags_names = [\"median\", \"other diseases\", \"symptoms\", \"course\"]\n",
    "lower_syns = []\n",
    "for syn in custom_syns:\n",
    "    lower_syns.append([s.lower() for s in syn])\n",
    "\n",
    "    \n",
    "def get_syn(ent, orig_text, start):\n",
    "    subtag = \"None\"\n",
    "    covid_syns = [\"covid\", \"sars-cov\", \"corona\", \"ncov\", \"cov infections\"]\n",
    "    severe_syns = [\"severe\"]\n",
    "    if any(word in ent.lower() for word in covid_syns) and any(word in ent.lower() for word in severe_syns):\n",
    "        ent = \"severe covid-19\"\n",
    "    elif any(word in ent.lower() for word in covid_syns) and \"pneumonia\" in ent.lower():\n",
    "        ent = \"COVID-19 pneumonia\"\n",
    "#     elif any(word in ent.lower() for word in severe_syns):\n",
    "#         return \"severe\"\n",
    "    else:\n",
    "        for l in lower_syns:\n",
    "            if ent.lower() in l:\n",
    "                ent =  l[0]\n",
    "        \n",
    "    if ent == \"severe\":\n",
    "        for i in range(len(severe_subtags)):\n",
    "            orig_text_split = orig_text.lower().split(\" \")\n",
    "            if len(orig_text_split) > start+1 and orig_text_split[start+1] in severe_subtags[i]:\n",
    "                subtag = severe_subtags_names[i]\n",
    "                \n",
    "    if ent == \"age\":\n",
    "        orig_text_split = orig_text.lower().split()\n",
    "        orig_text_split = [\"age\" if text == \"ages\" else text for text in orig_text_split]\n",
    "        \n",
    "        if \"child\" in orig_text.lower():\n",
    "            subtag = \"<18\"\n",
    "        elif \"years of age\" in orig_text.lower():\n",
    "            age_idx = orig_text_split.index(\"years\")\n",
    "            \n",
    "            age = orig_text_split[age_idx-3:age_idx]\n",
    "            if len(age) == 3:\n",
    "                if age[1] == \"under\" or age[0] in [\"younger\", \"less\"]:\n",
    "                    age = \"<\" + age[-1]\n",
    "\n",
    "                elif age[1] == \"over\" or age[0] in [\"older\", \"more\"]:\n",
    "                    age = \">\" + age[-1]   \n",
    "\n",
    "            subtag = \"\".join(age)\n",
    "        \n",
    "        elif \"years\" in orig_text.lower(): \n",
    "            age = orig_text_split[orig_text_split.index(\"age\")+1:orig_text_split.index(\"years\")]\n",
    "            if \"patients\" in age and age[age.index(\"patients\")-1].isnumeric():\n",
    "                age = age[age.index(\"patients\")+1:orig_text_split.index(\"years\")]\n",
    "                \n",
    "            age = \" \".join(age)\n",
    "            age = age.replace(\"to\", \"-\")\n",
    "            regex = re.compile('[a-zA-Z]')\n",
    "            subtag = regex.sub('', age)\n",
    "        else:\n",
    "            subtag = \"concept\"\n",
    "        \n",
    "#         if \"+-\" in subtag:\n",
    "#             subtag = subtag.replace(\" \", \"\")\n",
    "#             nums = [float(x) for x in subtag.split(\"+-\")]\n",
    "#             subtag = str(nums[0]-nums[1])-str(nums[0]+nums[1])\n",
    "        subtag = subtag.replace(\"[\", \"(\")\n",
    "        subtag = subtag.replace(\"]\", \")\")\n",
    "    return ent, subtag"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "re.search(\"^[0-9><()]\", \"w123\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Get data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "dirs: 100%|████████████████████████████████████████████████████████████████████████| 6459/6459 [01:53<00:00, 57.09it/s]\n"
     ]
    }
   ],
   "source": [
    "\n",
    "folder = \"../LitCovid_Treatment_json/\"\n",
    "dirs = os.listdir(folder)\n",
    "pmids = []\n",
    "entities = []\n",
    "\n",
    "singulars = 0\n",
    "for file in tqdm(dirs, desc = \"dirs\"):\n",
    "# for file in dirs[:3]:\n",
    "#     try:\n",
    "    if file not in [\"exceptionlist.txt\", \"label2id.pkl\", \"predict.tf_record\"]:\n",
    "\n",
    "        #get filepath and read in data\n",
    "        file_path = os.path.join(folder, file)\n",
    "        temp = pd.read_json(file_path)\n",
    "        pmid = file[:-5]\n",
    "        section = split_sections.get(pmid)\n",
    "\n",
    "#             if section[0][0] == \"TITLE\":\n",
    "#                 sec_idx = 1\n",
    "#             else:\n",
    "#                 sec_idx = 0\n",
    "#         print(temp)\n",
    "#         print(section)\n",
    "        for i in range(temp.shape[0]):\n",
    "\n",
    "            #get entities sentence by sentence\n",
    "            ents_dict = temp.sentences.values[i].get(\"entities\")\n",
    "            orig_text = temp.sentences.values[i].get(\"text\")\n",
    "\n",
    "            if i < len(section):\n",
    "                temp_sec = section[i][0]\n",
    "#                     sec_idx +=1\n",
    "\n",
    "            else:\n",
    "                temp_sec = \"ERROR\"\n",
    "\n",
    "            if len(ents_dict.keys()) > 0:\n",
    "                temp_ents = [(ents_dict[k][\"text\"], ents_dict[k][\"class\"], ents_dict[k][\"negation\"], ents_dict[k][\"start\"], orig_text, \"None\", temp_sec, pmid) for k in ents_dict.keys()]\n",
    "                true_ents = []\n",
    "                for i in range(len(temp_ents)):\n",
    "                    ent = temp_ents[i][0]\n",
    "                    cl = temp_ents[i][1]\n",
    "                    neg = temp_ents[i][2]\n",
    "                    start = temp_ents[i][3]\n",
    "                    subtag = temp_ents[i][5]\n",
    "#                     info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                    added = False\n",
    "\n",
    "                    if len(ent) > 1: #make sure it's not punctuation\n",
    "\n",
    "                        if len(ent.split()) > 1: #if phrase\n",
    "\n",
    "                            #check to see if it's in custom set of synonyms\n",
    "                            new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "                            info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                            true_ents.append(info_tuple)\n",
    "\n",
    "                        else: #if single word\n",
    "                            if ent.lower() not in stop_words: #if not stop word\n",
    "\n",
    "                                #check to see if it's in custom set of synonyms\n",
    "                                new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "\n",
    "                                if new_ent != ent:\n",
    "                                    info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                                    true_ents.append(info_tuple)\n",
    "\n",
    "                                else:\n",
    "                                    ent = singularize(ent)\n",
    "                                    new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "                                    info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                                    true_ents.append(info_tuple)       \n",
    "\n",
    "                                    \n",
    "                entities += true_ents\n",
    "#     except:\n",
    "#         print(pmid)\n",
    "#         print(section)\n",
    "#         print(temp.sentences.values)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>type</th>\n",
       "      <th>negation</th>\n",
       "      <th>start</th>\n",
       "      <th>sentence</th>\n",
       "      <th>subtag</th>\n",
       "      <th>section</th>\n",
       "      <th>pmid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>relevant</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>host defense against</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>This highlights the importance of immune respo...</td>\n",
       "      <td>None</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>14</td>\n",
       "      <td>As of January 22 , 2020 , a total of 571 cases...</td>\n",
       "      <td>None</td>\n",
       "      <td>TITLE</td>\n",
       "      <td>31996494</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>inflammation</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>inhibited</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>accelerate</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>accelerate its control .</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32015560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>control</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>accelerate its control .</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32015560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2019-nCoV infection</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>26</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>dead</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>26</td>\n",
       "      <td>Here , we focus on advances in research and de...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Persistent</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>H-bond</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>salt bridges</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>epitope</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>MHC-I</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>2019-nCoV surface</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>21</td>\n",
       "      <td>This study took an immunoinformatics approach ...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>interaction</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>Also , interactions between identified CTL epi...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Also , interactions between identified CTL epi...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>We identified five CTL epitopes , three sequen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>sequential B</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>We identified five CTL epitopes , three sequen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>CTL epitopes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>Also , during simulations , the CTL epitopes w...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>eight</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>B cell</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Epitope-MHC-I</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Epitope-MHC-I complexes were studied by molecu...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>remdesivir</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Herein , we suggest four potential drug candid...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022370</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121639</th>\n",
       "      <td>peak liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>In 30 % of patients with mild liver injury and...</td>\n",
       "      <td>None</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121640</th>\n",
       "      <td>detectable</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>was no longer detectable in the respiratory tr...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121641</th>\n",
       "      <td>Mild liver injury</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121642</th>\n",
       "      <td>worse</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121643</th>\n",
       "      <td>outcome</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121644</th>\n",
       "      <td>liver impairment</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>causing liver impairment .</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121645</th>\n",
       "      <td>severe liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121646</th>\n",
       "      <td>associated</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121647</th>\n",
       "      <td>multiple-organ failure</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121648</th>\n",
       "      <td>acute vascular events</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121649</th>\n",
       "      <td>prevalence of liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121650</th>\n",
       "      <td>mild vs severe liver injury</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>22</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121651</th>\n",
       "      <td>dead</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>28</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121652</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>COVID-19 patients and to scrutinize the tempor...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121653</th>\n",
       "      <td>liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>COVID-19 patients and to scrutinize the tempor...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121654</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>METHODS : We present data from a German cohort...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121655</th>\n",
       "      <td>elevated</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121656</th>\n",
       "      <td>alanine aminotransferase or</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121657</th>\n",
       "      <td>bilirubin</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121658</th>\n",
       "      <td>acute liver failure ( ALF )</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>20</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121659</th>\n",
       "      <td>Liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121660</th>\n",
       "      <td>75 ( 50.7 % )</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121661</th>\n",
       "      <td>93 ( 63 % )</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121662</th>\n",
       "      <td>ALF</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121663</th>\n",
       "      <td>associated</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121664</th>\n",
       "      <td>male</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121665</th>\n",
       "      <td>younger</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121666</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121667</th>\n",
       "      <td>higher</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121668</th>\n",
       "      <td>BMI</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>121669 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                               text          type  negation  start  \\\n",
       "0                          covid-19   Participant         0      9   \n",
       "1                          relevant   Participant         0     12   \n",
       "2              host defense against       Outcome         0     17   \n",
       "3                          covid-19   Participant         0      8   \n",
       "4                          covid-19   Participant         0     14   \n",
       "5                      inflammation       Outcome         0      9   \n",
       "6                          covid-19   Participant         0     11   \n",
       "7                         inhibited      modifier         0     13   \n",
       "8                        accelerate      modifier         0      0   \n",
       "9                           control       Outcome         0      2   \n",
       "10              2019-nCoV infection   Participant         0     12   \n",
       "11                               26       measure         0     16   \n",
       "12                             dead       Outcome         0     17   \n",
       "13                         covid-19       Outcome         0     26   \n",
       "14                       Persistent      modifier         0      0   \n",
       "15                           H-bond       Outcome         0      1   \n",
       "16                     salt bridges       Outcome         0      3   \n",
       "17                          epitope  Intervention         0      8   \n",
       "18                            MHC-I  Intervention         0     10   \n",
       "19                2019-nCoV surface   Participant         0     21   \n",
       "20                      interaction       Outcome         0      2   \n",
       "21                              CTL  Intervention         0      5   \n",
       "22                              CTL       Outcome         0      3   \n",
       "23                     sequential B       Outcome         0      7   \n",
       "24                     CTL epitopes  Intervention         0      6   \n",
       "25                              CTL       Outcome         0      1   \n",
       "26                            eight       measure         0      4   \n",
       "27                           B cell       Outcome         0      5   \n",
       "28                    Epitope-MHC-I       Outcome         0      0   \n",
       "29                       remdesivir  Intervention         0     13   \n",
       "...                             ...           ...       ...    ...   \n",
       "121639            peak liver injury       Outcome         0     17   \n",
       "121640                   detectable      modifier         0      3   \n",
       "121641            Mild liver injury   Participant         0      2   \n",
       "121642                        worse      modifier         0      9   \n",
       "121643                      outcome       Outcome         0     10   \n",
       "121644             liver impairment       Outcome         0      1   \n",
       "121645          severe liver injury       Outcome         0      2   \n",
       "121646                   associated      modifier         0      9   \n",
       "121647       multiple-organ failure       Outcome         0     10   \n",
       "121648        acute vascular events       Outcome         0     13   \n",
       "121649   prevalence of liver injury       Outcome         0      9   \n",
       "121650  mild vs severe liver injury  Intervention         0     22   \n",
       "121651                         dead       Outcome         0     28   \n",
       "121652                     covid-19  Intervention         0      0   \n",
       "121653                 liver injury       Outcome         0     12   \n",
       "121654                     covid-19   Participant         0     11   \n",
       "121655                     elevated   Participant         0      6   \n",
       "121656  alanine aminotransferase or   Participant         0      7   \n",
       "121657                    bilirubin   Participant         0     10   \n",
       "121658  acute liver failure ( ALF )   Participant         0     20   \n",
       "121659                 Liver injury       Outcome         0      2   \n",
       "121660                75 ( 50.7 % )       measure         0      7   \n",
       "121661                  93 ( 63 % )       measure         0     13   \n",
       "121662                          ALF       Outcome         0      0   \n",
       "121663                   associated      modifier         0      2   \n",
       "121664                         male   Participant         0      5   \n",
       "121665                      younger      modifier         0      8   \n",
       "121666                          age   Participant         0      9   \n",
       "121667                       higher      modifier         0     11   \n",
       "121668                          BMI   Participant         0     12   \n",
       "\n",
       "                                                 sentence   subtag  \\\n",
       "0       In this review , we provide an update on CoV i...     None   \n",
       "1       In this review , we provide an update on CoV i...     None   \n",
       "2       In this review , we provide an update on CoV i...     None   \n",
       "3       This highlights the importance of immune respo...     None   \n",
       "4       As of January 22 , 2020 , a total of 571 cases...     None   \n",
       "5       Here , we propose for the first time that infl...     None   \n",
       "6       Here , we propose for the first time that infl...     None   \n",
       "7       Here , we propose for the first time that infl...     None   \n",
       "8                                accelerate its control .     None   \n",
       "9                                accelerate its control .     None   \n",
       "10      As of 24 January 2020 , there were 887 confirm...     None   \n",
       "11      As of 24 January 2020 , there were 887 confirm...     None   \n",
       "12      As of 24 January 2020 , there were 887 confirm...     None   \n",
       "13      Here , we focus on advances in research and de...     None   \n",
       "14      Persistent H-bonds and salt bridges were obser...     None   \n",
       "15      Persistent H-bonds and salt bridges were obser...     None   \n",
       "16      Persistent H-bonds and salt bridges were obser...     None   \n",
       "17      Persistent H-bonds and salt bridges were obser...     None   \n",
       "18      Persistent H-bonds and salt bridges were obser...     None   \n",
       "19      This study took an immunoinformatics approach ...     None   \n",
       "20      Also , interactions between identified CTL epi...     None   \n",
       "21      Also , interactions between identified CTL epi...     None   \n",
       "22      We identified five CTL epitopes , three sequen...     None   \n",
       "23      We identified five CTL epitopes , three sequen...     None   \n",
       "24      Also , during simulations , the CTL epitopes w...     None   \n",
       "25      Five CTL epitopes and eight B cell epitopes we...     None   \n",
       "26      Five CTL epitopes and eight B cell epitopes we...     None   \n",
       "27      Five CTL epitopes and eight B cell epitopes we...     None   \n",
       "28      Epitope-MHC-I complexes were studied by molecu...     None   \n",
       "29      Herein , we suggest four potential drug candid...     None   \n",
       "...                                                   ...      ...   \n",
       "121639  In 30 % of patients with mild liver injury and...     None   \n",
       "121640  was no longer detectable in the respiratory tr...     None   \n",
       "121641  CONCLUSION : Mild liver injury was not associa...     None   \n",
       "121642  CONCLUSION : Mild liver injury was not associa...     None   \n",
       "121643  CONCLUSION : Mild liver injury was not associa...     None   \n",
       "121644                         causing liver impairment .     None   \n",
       "121645  Instead , severe liver injury in our cohort wa...     None   \n",
       "121646  Instead , severe liver injury in our cohort wa...     None   \n",
       "121647  Instead , severe liver injury in our cohort wa...     None   \n",
       "121648  Instead , severe liver injury in our cohort wa...     None   \n",
       "121649  Aim of our study was to report on the prevalen...     None   \n",
       "121650  Aim of our study was to report on the prevalen...     None   \n",
       "121651  Aim of our study was to report on the prevalen...     None   \n",
       "121652  COVID-19 patients and to scrutinize the tempor...     None   \n",
       "121653  COVID-19 patients and to scrutinize the tempor...     None   \n",
       "121654  METHODS : We present data from a German cohort...     None   \n",
       "121655  The first group included patients without elev...     None   \n",
       "121656  The first group included patients without elev...     None   \n",
       "121657  The first group included patients without elev...     None   \n",
       "121658  The first group included patients without elev...     None   \n",
       "121659  RESULTS : Liver injury was detected in 75 ( 50...     None   \n",
       "121660  RESULTS : Liver injury was detected in 75 ( 50...     None   \n",
       "121661  RESULTS : Liver injury was detected in 75 ( 50...     None   \n",
       "121662  ALF was associated with the male sex , younger...     None   \n",
       "121663  ALF was associated with the male sex , younger...     None   \n",
       "121664  ALF was associated with the male sex , younger...     None   \n",
       "121665  ALF was associated with the male sex , younger...     None   \n",
       "121666  ALF was associated with the male sex , younger...  concept   \n",
       "121667  ALF was associated with the male sex , younger...     None   \n",
       "121668  ALF was associated with the male sex , younger...     None   \n",
       "\n",
       "            section      pmid  \n",
       "0        BACKGROUND  31981224  \n",
       "1        BACKGROUND  31981224  \n",
       "2        BACKGROUND  31981224  \n",
       "3       CONCLUSIONS  31981224  \n",
       "4             TITLE  31996494  \n",
       "5           RESULTS  32013309  \n",
       "6           RESULTS  32013309  \n",
       "7           RESULTS  32013309  \n",
       "8        BACKGROUND  32015560  \n",
       "9        BACKGROUND  32015560  \n",
       "10       BACKGROUND  32017984  \n",
       "11       BACKGROUND  32017984  \n",
       "12       BACKGROUND  32017984  \n",
       "13       BACKGROUND  32017984  \n",
       "14       BACKGROUND  32022276  \n",
       "15       BACKGROUND  32022276  \n",
       "16       BACKGROUND  32022276  \n",
       "17       BACKGROUND  32022276  \n",
       "18       BACKGROUND  32022276  \n",
       "19          RESULTS  32022276  \n",
       "20          RESULTS  32022276  \n",
       "21          RESULTS  32022276  \n",
       "22          RESULTS  32022276  \n",
       "23          RESULTS  32022276  \n",
       "24          RESULTS  32022276  \n",
       "25          RESULTS  32022276  \n",
       "26          RESULTS  32022276  \n",
       "27          RESULTS  32022276  \n",
       "28          RESULTS  32022276  \n",
       "29          RESULTS  32022370  \n",
       "...             ...       ...  \n",
       "121639    OBJECTIVE  32777784  \n",
       "121640      METHODS  32777784  \n",
       "121641      METHODS  32777784  \n",
       "121642      METHODS  32777784  \n",
       "121643      METHODS  32777784  \n",
       "121644      METHODS  32777784  \n",
       "121645      METHODS  32777784  \n",
       "121646      METHODS  32777784  \n",
       "121647      METHODS  32777784  \n",
       "121648      METHODS  32777784  \n",
       "121649      RESULTS  32777784  \n",
       "121650      RESULTS  32777784  \n",
       "121651      RESULTS  32777784  \n",
       "121652      RESULTS  32777784  \n",
       "121653      RESULTS  32777784  \n",
       "121654      RESULTS  32777784  \n",
       "121655      RESULTS  32777784  \n",
       "121656      RESULTS  32777784  \n",
       "121657      RESULTS  32777784  \n",
       "121658      RESULTS  32777784  \n",
       "121659      RESULTS  32777784  \n",
       "121660      RESULTS  32777784  \n",
       "121661      RESULTS  32777784  \n",
       "121662      RESULTS  32777784  \n",
       "121663      RESULTS  32777784  \n",
       "121664      RESULTS  32777784  \n",
       "121665      RESULTS  32777784  \n",
       "121666      RESULTS  32777784  \n",
       "121667      RESULTS  32777784  \n",
       "121668      RESULTS  32777784  \n",
       "\n",
       "[121669 rows x 8 columns]"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent_df = pd.DataFrame(entities, columns=[\"text\", \"type\", \"negation\", \"start\", \"sentence\", \"subtag\", \"section\", \"pmid\"])\n",
    "# ent_df.to_csv(\"LitCovid_treatment_ents.csv\")\n",
    "ent_df\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>type</th>\n",
       "      <th>negation</th>\n",
       "      <th>start</th>\n",
       "      <th>sentence</th>\n",
       "      <th>subtag</th>\n",
       "      <th>section</th>\n",
       "      <th>pmid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>A total of 14 children ( 6 months to 14 years ...</td>\n",
       "      <td>&lt;18</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32051073</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>719</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age of the 52 patients was 59 7 ( SD ...</td>\n",
       "      <td>59 7 (  13 3 )</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32105632</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1728</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>Results : Of 201 patients , the median age was...</td>\n",
       "      <td>51</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32167524</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1850</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>Results : The age of the 54 patients was 68.0 ...</td>\n",
       "      <td>68.0 ( 59.8 , 74.3 )</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32171190</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1956</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>Indeed , age and disease severity may be corre...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32173241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2037</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>Compared with general COVID-19 patients ( 45.2...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32173725</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2123</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The median age of 69 enrolled patients was 42....</td>\n",
       "      <td>69    42.0</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32176772</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2590</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The median age was 47 years ( interquartile ra...</td>\n",
       "      <td>47</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>32198776</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3111</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>The mean ( SD ) age was 58.50 ( 14.66 ) years .</td>\n",
       "      <td>58.50 ( 14.66 )</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32219356</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3238</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>Results : All 5 patients ( age range , 36-65 y...</td>\n",
       "      <td>, 36-65</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32219428</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3328</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>14</td>\n",
       "      <td>Our study showed that comorbidity , time from ...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32220033</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3490</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>Results : The median age of 7 patients was 59 ...</td>\n",
       "      <td>59</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32220276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3552</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>22</td>\n",
       "      <td>Current research shows that the poor prognosis...</td>\n",
       "      <td>( &gt; 60</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32221983</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3642</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>The differences in age , sex , and last CT sco...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32223665</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3659</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>difference in age and sex between the groups .</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32223665</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3737</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Median ( interquartile range ) age was 65.0 ( ...</td>\n",
       "      <td>65.0 ( 56.0-70.0 )</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>32224151</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4557</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>Measurements and Main Results : The median age...</td>\n",
       "      <td>65.8</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32242738</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4692</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>of cancer , patients ' comorbidities , age and...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32245904</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6322</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>Median [ interquartile range ( IQR ) ] age of ...</td>\n",
       "      <td>63 ( 51-75 )</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32278670</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6358</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Older age , diabetes and other comorbidities a...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32278764</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8237</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Median age at diagnosis was 71.0 +- 12.8 years...</td>\n",
       "      <td>71.0 +- 12.8</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32301155</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8630</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>Multivariate Cox regression analysis showed th...</td>\n",
       "      <td>&gt; = 75</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32304772</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8633</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>27</td>\n",
       "      <td>Multivariate Cox regression analysis showed th...</td>\n",
       "      <td>&gt; = 75</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32304772</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8756</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>Comorbidities , in particular , diabetes and h...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32305831</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9101</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The elder age , more neutrophils numbers and h...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32307550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9248</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>22</td>\n",
       "      <td>SARS-CoV , MERS-CoV and SARS-CoV-2 seem to les...</td>\n",
       "      <td>&lt;18</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32310621</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9555</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age and body mass index were 46 +- 12...</td>\n",
       "      <td>46 +- 12</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32314249</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9603</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>They had a median ( interquartile range [ IQR ...</td>\n",
       "      <td>47.0 ( 38.0-70.3 )</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32314455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10206</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>The median ( range ) age was 73 ( 38-91 ) years .</td>\n",
       "      <td>73 ( 38-91 )</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32318325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10498</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Simulations showed differences in drug exposur...</td>\n",
       "      <td>&lt;18</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32320477</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118321</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age was 61.8+-18.3 years , 17 ( 51.5 ...</td>\n",
       "      <td>61.8+-18.3</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32767353</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118640</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Median age of patients by study ranged from 7....</td>\n",
       "      <td>7.3 - 10</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32768466</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118830</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>age 56 years ) treated with SOC only were incl...</td>\n",
       "      <td>56</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32768701</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119005</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>Additionally , the probability of death was mu...</td>\n",
       "      <td>&gt;40</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32769026</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119109</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age on admission was 69.7 ( 15.7 ) ye...</td>\n",
       "      <td>69.7 ( 15.7 )</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32769150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119121</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Compared with outpatients , the factors indepe...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32769150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119127</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>Our results suggest that age and having a syst...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32769150</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119402</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The general data of patients , including age ,...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32769892</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119679</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Participants of any gender or age group having...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32771032</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119889</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>24</td>\n",
       "      <td>CONCLUSIONS : Among hospitalized patients 65 y...</td>\n",
       "      <td></td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32771560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120040</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>In logistic regression analysis , predictive f...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32771883</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120224</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>making age the most significant risk factor fo...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32772513</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120231</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>25</td>\n",
       "      <td>To examine the effect of age on death , we est...</td>\n",
       "      <td>concept</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32772513</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120286</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>Using our institutional electronic health reco...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32772679</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120360</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>From these records , information was obtained ...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120401</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>Increased quarantine duration was associated w...</td>\n",
       "      <td>&gt; =40</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32773262</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120426</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>CONCLUSION : COVID-19 patients with older age ...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32773262</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120458</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The development of pneumonia was associated wi...</td>\n",
       "      <td>&gt; =40</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32773262</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120594</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>25</td>\n",
       "      <td>Interpretation &amp; conclusions : : In this singl...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32773414</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120613</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age of the patients was 40.1 13.1 yr ...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32773414</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120668</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Median age was 44 years , CD4 T cells were 618...</td>\n",
       "      <td>44</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32773471</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120696</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>By multivariate analysis , age , male sex , et...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32773476</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120776</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Correlation was tested among all predictors ( ...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32774918</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120887</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>Results : Median age was 56 years , with 55 % ...</td>\n",
       "      <td>56</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32775814</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121044</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>RESULTS : Mean age of the patients was 72 +- 1...</td>\n",
       "      <td>72 +- 14</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776197</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121417</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>The mean age was 60 years .</td>\n",
       "      <td>60</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121425</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Significant age differences were not found amo...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121541</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>14</td>\n",
       "      <td>In total , 29 COVID-19-related deaths were rep...</td>\n",
       "      <td>concept</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121573</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>19</td>\n",
       "      <td>Viral infection occurred more frequently in ma...</td>\n",
       "      <td>14 - 85</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121666</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>concept</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>658 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       text         type  negation  start  \\\n",
       "147     age  Participant         0     12   \n",
       "719     age  Participant         0      2   \n",
       "1728    age  Participant         0      8   \n",
       "1850    age  Participant         0      3   \n",
       "1956    age  Participant         0      2   \n",
       "2037    age  Participant         0     15   \n",
       "2123    age  Participant         0      2   \n",
       "2590    age  Participant         0      2   \n",
       "3111    age  Participant         0      5   \n",
       "3238    age  Participant         0      6   \n",
       "3328    age  Participant         0     14   \n",
       "3490    age  Participant         0      4   \n",
       "3552    age  Participant         0     22   \n",
       "3642    age  Participant         0      3   \n",
       "3659    age  Participant         0      2   \n",
       "3737    age  Participant         0      5   \n",
       "4557    age  Participant         0      7   \n",
       "4692    age  Participant         0      7   \n",
       "6322    age  Participant         0      8   \n",
       "6358    age  Participant         0      1   \n",
       "8237    age  Participant         0      1   \n",
       "8630    age  Participant         0      6   \n",
       "8633    age  Participant         0     27   \n",
       "8756    age  Participant         0     12   \n",
       "9101    age  Participant         0      2   \n",
       "9248    age  Participant         0     22   \n",
       "9555    age  Participant         0      2   \n",
       "9603    age  Participant         0     11   \n",
       "10206   age  Participant         0      5   \n",
       "10498   age  Participant         0     10   \n",
       "...     ...          ...       ...    ...   \n",
       "118321  age  Participant         0      2   \n",
       "118640  age  Participant         0      1   \n",
       "118830  age  Participant         0      0   \n",
       "119005  age  Participant         0     16   \n",
       "119109  age  Participant         0      2   \n",
       "119121  age  Participant         0     13   \n",
       "119127  age  Participant         0      4   \n",
       "119402  age  Participant         0      7   \n",
       "119679  age  Participant         0      5   \n",
       "119889  age  Participant         0     24   \n",
       "120040  age  Participant         0     10   \n",
       "120224  age  Participant         0      1   \n",
       "120231  age  Participant         0     25   \n",
       "120286  age  Participant         0     16   \n",
       "120360  age  Participant         0     10   \n",
       "120401  age  Participant         0      6   \n",
       "120426  age  Participant         0      6   \n",
       "120458  age  Participant         0      7   \n",
       "120594  age  Participant         0     25   \n",
       "120613  age  Participant         0      2   \n",
       "120668  age  Participant         0      1   \n",
       "120696  age  Participant         0      4   \n",
       "120776  age  Participant         0      9   \n",
       "120887  age  Participant         0      3   \n",
       "121044  age  Participant         0      3   \n",
       "121417  age  Participant         0      2   \n",
       "121425  age  Participant         0      1   \n",
       "121541  age  Participant         0     14   \n",
       "121573  age  Participant         0     19   \n",
       "121666  age  Participant         0      9   \n",
       "\n",
       "                                                 sentence  \\\n",
       "147     A total of 14 children ( 6 months to 14 years ...   \n",
       "719     The mean age of the 52 patients was 59 7 ( SD ...   \n",
       "1728    Results : Of 201 patients , the median age was...   \n",
       "1850    Results : The age of the 54 patients was 68.0 ...   \n",
       "1956    Indeed , age and disease severity may be corre...   \n",
       "2037    Compared with general COVID-19 patients ( 45.2...   \n",
       "2123    The median age of 69 enrolled patients was 42....   \n",
       "2590    The median age was 47 years ( interquartile ra...   \n",
       "3111      The mean ( SD ) age was 58.50 ( 14.66 ) years .   \n",
       "3238    Results : All 5 patients ( age range , 36-65 y...   \n",
       "3328    Our study showed that comorbidity , time from ...   \n",
       "3490    Results : The median age of 7 patients was 59 ...   \n",
       "3552    Current research shows that the poor prognosis...   \n",
       "3642    The differences in age , sex , and last CT sco...   \n",
       "3659       difference in age and sex between the groups .   \n",
       "3737    Median ( interquartile range ) age was 65.0 ( ...   \n",
       "4557    Measurements and Main Results : The median age...   \n",
       "4692    of cancer , patients ' comorbidities , age and...   \n",
       "6322    Median [ interquartile range ( IQR ) ] age of ...   \n",
       "6358    Older age , diabetes and other comorbidities a...   \n",
       "8237    Median age at diagnosis was 71.0 +- 12.8 years...   \n",
       "8630    Multivariate Cox regression analysis showed th...   \n",
       "8633    Multivariate Cox regression analysis showed th...   \n",
       "8756    Comorbidities , in particular , diabetes and h...   \n",
       "9101    The elder age , more neutrophils numbers and h...   \n",
       "9248    SARS-CoV , MERS-CoV and SARS-CoV-2 seem to les...   \n",
       "9555    The mean age and body mass index were 46 +- 12...   \n",
       "9603    They had a median ( interquartile range [ IQR ...   \n",
       "10206   The median ( range ) age was 73 ( 38-91 ) years .   \n",
       "10498   Simulations showed differences in drug exposur...   \n",
       "...                                                   ...   \n",
       "118321  The mean age was 61.8+-18.3 years , 17 ( 51.5 ...   \n",
       "118640  Median age of patients by study ranged from 7....   \n",
       "118830  age 56 years ) treated with SOC only were incl...   \n",
       "119005  Additionally , the probability of death was mu...   \n",
       "119109  The mean age on admission was 69.7 ( 15.7 ) ye...   \n",
       "119121  Compared with outpatients , the factors indepe...   \n",
       "119127  Our results suggest that age and having a syst...   \n",
       "119402  The general data of patients , including age ,...   \n",
       "119679  Participants of any gender or age group having...   \n",
       "119889  CONCLUSIONS : Among hospitalized patients 65 y...   \n",
       "120040  In logistic regression analysis , predictive f...   \n",
       "120224  making age the most significant risk factor fo...   \n",
       "120231  To examine the effect of age on death , we est...   \n",
       "120286  Using our institutional electronic health reco...   \n",
       "120360  From these records , information was obtained ...   \n",
       "120401  Increased quarantine duration was associated w...   \n",
       "120426  CONCLUSION : COVID-19 patients with older age ...   \n",
       "120458  The development of pneumonia was associated wi...   \n",
       "120594  Interpretation & conclusions : : In this singl...   \n",
       "120613  The mean age of the patients was 40.1 13.1 yr ...   \n",
       "120668  Median age was 44 years , CD4 T cells were 618...   \n",
       "120696  By multivariate analysis , age , male sex , et...   \n",
       "120776  Correlation was tested among all predictors ( ...   \n",
       "120887  Results : Median age was 56 years , with 55 % ...   \n",
       "121044  RESULTS : Mean age of the patients was 72 +- 1...   \n",
       "121417                        The mean age was 60 years .   \n",
       "121425  Significant age differences were not found amo...   \n",
       "121541  In total , 29 COVID-19-related deaths were rep...   \n",
       "121573  Viral infection occurred more frequently in ma...   \n",
       "121666  ALF was associated with the male sex , younger...   \n",
       "\n",
       "                       subtag      section      pmid  \n",
       "147                       <18      RESULTS  32051073  \n",
       "719            59 7 (  13 3 )   BACKGROUND  32105632  \n",
       "1728                       51   BACKGROUND  32167524  \n",
       "1850     68.0 ( 59.8 , 74.3 )      METHODS  32171190  \n",
       "1956                  concept   BACKGROUND  32173241  \n",
       "2037                  concept      RESULTS  32173725  \n",
       "2123               69    42.0      RESULTS  32176772  \n",
       "2590                       47  CONCLUSIONS  32198776  \n",
       "3111          58.50 ( 14.66 )   BACKGROUND  32219356  \n",
       "3238                  , 36-65      METHODS  32219428  \n",
       "3328                  concept   BACKGROUND  32220033  \n",
       "3490                       59      METHODS  32220276  \n",
       "3552                   ( > 60      RESULTS  32221983  \n",
       "3642                  concept   BACKGROUND  32223665  \n",
       "3659                  concept      METHODS  32223665  \n",
       "3737       65.0 ( 56.0-70.0 )  CONCLUSIONS  32224151  \n",
       "4557                     65.8      METHODS  32242738  \n",
       "4692                  concept   BACKGROUND  32245904  \n",
       "6322             63 ( 51-75 )      RESULTS  32278670  \n",
       "6358                  concept   BACKGROUND  32278764  \n",
       "8237             71.0 +- 12.8      RESULTS  32301155  \n",
       "8630                   > = 75   BACKGROUND  32304772  \n",
       "8633                   > = 75   BACKGROUND  32304772  \n",
       "8756                  concept      RESULTS  32305831  \n",
       "9101                  concept      RESULTS  32307550  \n",
       "9248                      <18      RESULTS  32310621  \n",
       "9555                 46 +- 12      RESULTS  32314249  \n",
       "9603       47.0 ( 38.0-70.3 )      RESULTS  32314455  \n",
       "10206            73 ( 38-91 )      RESULTS  32318325  \n",
       "10498                     <18   BACKGROUND  32320477  \n",
       "...                       ...          ...       ...  \n",
       "118321             61.8+-18.3   BACKGROUND  32767353  \n",
       "118640               7.3 - 10      RESULTS  32768466  \n",
       "118830                     56      METHODS  32768701  \n",
       "119005                    >40      METHODS  32769026  \n",
       "119109          69.7 ( 15.7 )    OBJECTIVE  32769150  \n",
       "119121                concept      METHODS  32769150  \n",
       "119127                concept      METHODS  32769150  \n",
       "119402                concept      RESULTS  32769892  \n",
       "119679                concept      METHODS  32771032  \n",
       "119889                          BACKGROUND  32771560  \n",
       "120040                concept      RESULTS  32771883  \n",
       "120224                concept   BACKGROUND  32772513  \n",
       "120231                concept   BACKGROUND  32772513  \n",
       "120286                concept      RESULTS  32772679  \n",
       "120360                concept      RESULTS  32773165  \n",
       "120401                  > =40   BACKGROUND  32773262  \n",
       "120426                concept      RESULTS  32773262  \n",
       "120458                  > =40      RESULTS  32773262  \n",
       "120594                concept      METHODS  32773414  \n",
       "120613                concept      METHODS  32773414  \n",
       "120668                     44      RESULTS  32773471  \n",
       "120696                concept      RESULTS  32773476  \n",
       "120776                concept      METHODS  32774918  \n",
       "120887                     56      METHODS  32775814  \n",
       "121044               72 +- 14      RESULTS  32776197  \n",
       "121417                     60      RESULTS  32777153  \n",
       "121425                concept      RESULTS  32777153  \n",
       "121541                concept      METHODS  32777550  \n",
       "121573                14 - 85      RESULTS  32777550  \n",
       "121666                concept      RESULTS  32777784  \n",
       "\n",
       "[658 rows x 8 columns]"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent_df[(ent_df.text == \"age\")&(ent_df.type == \"Participant\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "118321A"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 246,
   "metadata": {},
   "outputs": [],
   "source": [
    "ent_df[ent_df.type == \"Participant\"].groupby(\"pmid\").text.unique().iloc[:20].to_csv(\"example_ptags.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 243,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>type</th>\n",
       "      <th>negation</th>\n",
       "      <th>start</th>\n",
       "      <th>sentence</th>\n",
       "      <th>subtag</th>\n",
       "      <th>section</th>\n",
       "      <th>pmid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>10944</th>\n",
       "      <td>ACEI/ARBs .</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>% ] were men ) , of whom 115 ( 31.8 % ) were t...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10949</th>\n",
       "      <td>ACEIs/ARBs did not</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The percentage of patients with hypertension t...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10961</th>\n",
       "      <td>ACEI</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>Similar findings were observed when data were ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10962</th>\n",
       "      <td>ARB</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>Similar findings were observed when data were ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10963</th>\n",
       "      <td>ACEIs/ARBs and outcomes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Conclusions and Relevance : This study provide...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10970</th>\n",
       "      <td>ACEIs/ARBs and severity</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>Objective : To investigate the association bet...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10978</th>\n",
       "      <td>nonsurvivor</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>21</td>\n",
       "      <td>The percentage of patients with hypertension t...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32324209</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18980</th>\n",
       "      <td>Dyspnea</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Dyspnea was also independently associated with...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32376101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19011</th>\n",
       "      <td>SpO2 levels</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Higher SpO2 levels after oxygen supplementatio...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32376101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19012</th>\n",
       "      <td>oxygen supplementation</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>Higher SpO2 levels after oxygen supplementatio...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32376101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22060</th>\n",
       "      <td>high level of cTnI</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>The single cut-off point and high level of cTn...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32391877</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22173</th>\n",
       "      <td>azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>azithromycin , or both were more likely than t...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22175</th>\n",
       "      <td>either drug</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>azithromycin , or both were more likely than t...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22186</th>\n",
       "      <td>hydroxychloroquine + azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The probability of death for patients receivin...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22188</th>\n",
       "      <td>alone</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>28</td>\n",
       "      <td>The probability of death for patients receivin...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22191</th>\n",
       "      <td>alone</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>54/271 ( 19.9 % [ 95 % CI , 15.2 % -24.7 % ] )...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22194</th>\n",
       "      <td>neither drug</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>-14.0 % ] ) , and neither drug , 28/221 ( 12.7...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22197</th>\n",
       "      <td>neither drug</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>In adjusted Cox proportional hazards models , ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22200</th>\n",
       "      <td>hydroxychloroquine + azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>24</td>\n",
       "      <td>In adjusted Cox proportional hazards models , ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22202</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>1.35 [ 95 % CI , 0.76-2.40 ] ) , hydroxychloro...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22204</th>\n",
       "      <td>azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>26</td>\n",
       "      <td>1.35 [ 95 % CI , 0.76-2.40 ] ) , hydroxychloro...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22205</th>\n",
       "      <td>neither drug</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>In logistic models , compared with patients re...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22208</th>\n",
       "      <td>hydroxychloroquine + azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>19</td>\n",
       "      <td>In logistic models , compared with patients re...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22209</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>CI , 1.12-4.05 ] ) , but not hydroxychloroquin...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22210</th>\n",
       "      <td>azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>24</td>\n",
       "      <td>CI , 1.12-4.05 ] ) , but not hydroxychloroquin...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22215</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>Conclusions and Relevance : Among patients hos...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22216</th>\n",
       "      <td>azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>18</td>\n",
       "      <td>Conclusions and Relevance : Among patients hos...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22217</th>\n",
       "      <td>neither treatment</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>25</td>\n",
       "      <td>Conclusions and Relevance : Among patients hos...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22221</th>\n",
       "      <td>azithromycin</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>14</td>\n",
       "      <td>Objective : To describe the association betwee...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22232</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Exposures : Receipt of both hydroxychloroquine...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32392282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117736</th>\n",
       "      <td>severe</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>No differences were observed of antibody level...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32766541</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117737</th>\n",
       "      <td>non-severe</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>No differences were observed of antibody level...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32766541</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120340</th>\n",
       "      <td>combination</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>RESULTS : The most frequently used combination...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120341</th>\n",
       "      <td>low molecular weight heparins</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>RESULTS : The most frequently used combination...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120342</th>\n",
       "      <td>ritonavir/lopinavir .</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>18</td>\n",
       "      <td>RESULTS : The most frequently used combination...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120343</th>\n",
       "      <td>analysed</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>None of the analysed treatments showed indepen...</td>\n",
       "      <td>None</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120348</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>The drugs that showed a greater inverse associ...</td>\n",
       "      <td>None</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120349</th>\n",
       "      <td>corticoid</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>The drugs that showed a greater inverse associ...</td>\n",
       "      <td>None</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120350</th>\n",
       "      <td>tocilizumab</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>It seems necessary to design randomized contro...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120351</th>\n",
       "      <td>corticoid</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>18</td>\n",
       "      <td>It seems necessary to design randomized contro...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120354</th>\n",
       "      <td>in-hospital treatments</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>The aim of this study was to assess the patter...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120367</th>\n",
       "      <td>therapeutic alternatives</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>To estimate the associations between the diffe...</td>\n",
       "      <td>None</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>32773165</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121020</th>\n",
       "      <td>pre-existing diabetes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>PURPOSE : The purpose of this study was to eva...</td>\n",
       "      <td>None</td>\n",
       "      <td>TITLE</td>\n",
       "      <td>32776197</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121034</th>\n",
       "      <td>diabetes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>CONCLUSION : In this retrospective single-cent...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776197</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121042</th>\n",
       "      <td>diabetes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Multivariable logistic regression was performe...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776197</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121065</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>There was no significant difference ( HCQ vs. ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121066</th>\n",
       "      <td>) in hospital</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>There was no significant difference ( HCQ vs. ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121080</th>\n",
       "      <td>both groups</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>A PCR negativity from nasopharyngeal swabs was...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121084</th>\n",
       "      <td>LPV/RTV group .</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Side effects led to treatment discontinuation ...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121087</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>15</td>\n",
       "      <td>CONCLUSION : No statistically significant diff...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121088</th>\n",
       "      <td>LPV/RTV but patients</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>CONCLUSION : No statistically significant diff...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121089</th>\n",
       "      <td>showed a numerically</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>24</td>\n",
       "      <td>CONCLUSION : No statistically significant diff...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121092</th>\n",
       "      <td>LPV/RTV despite having</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>Additionally , in comparison to other studies ...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121093</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>To date no trial comparing hydroxychloroquine ...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121094</th>\n",
       "      <td>lopinavir/ritonavir ( LPV/RTV</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>To date no trial comparing hydroxychloroquine ...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121097</th>\n",
       "      <td>if they had</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>23</td>\n",
       "      <td>METHODS : Hospitalized patients &gt; =18 years ol...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32776298</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121439</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>These findings indicate that hydroxychloroquin...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32777263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121444</th>\n",
       "      <td>hydroxychloroquine</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>The primary objective of this study was to ass...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121449</th>\n",
       "      <td>hydroxychloroquine plasma concentration</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>The study compared 17 patients in whom the hyd...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121452</th>\n",
       "      <td>hydroxychloroquine plasma concentration</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>No association was found between hydroxychloro...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777263</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>365 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                           text          type  negation  \\\n",
       "10944                               ACEI/ARBs .  Intervention         0   \n",
       "10949                        ACEIs/ARBs did not  Intervention         0   \n",
       "10961                                      ACEI  Intervention         0   \n",
       "10962                                       ARB  Intervention         0   \n",
       "10963                   ACEIs/ARBs and outcomes  Intervention         0   \n",
       "10970                   ACEIs/ARBs and severity  Intervention         0   \n",
       "10978                               nonsurvivor  Intervention         0   \n",
       "18980                                   Dyspnea  Intervention         0   \n",
       "19011                               SpO2 levels  Intervention         0   \n",
       "19012                    oxygen supplementation  Intervention         0   \n",
       "22060                        high level of cTnI  Intervention         0   \n",
       "22173                              azithromycin  Intervention         0   \n",
       "22175                               either drug  Intervention         0   \n",
       "22186         hydroxychloroquine + azithromycin  Intervention         0   \n",
       "22188                                     alone  Intervention         0   \n",
       "22191                                     alone  Intervention         0   \n",
       "22194                              neither drug  Intervention         0   \n",
       "22197                              neither drug  Intervention         0   \n",
       "22200         hydroxychloroquine + azithromycin  Intervention         0   \n",
       "22202                        hydroxychloroquine  Intervention         0   \n",
       "22204                              azithromycin  Intervention         0   \n",
       "22205                              neither drug  Intervention         0   \n",
       "22208         hydroxychloroquine + azithromycin  Intervention         0   \n",
       "22209                        hydroxychloroquine  Intervention         0   \n",
       "22210                              azithromycin  Intervention         0   \n",
       "22215                        hydroxychloroquine  Intervention         0   \n",
       "22216                              azithromycin  Intervention         0   \n",
       "22217                         neither treatment  Intervention         0   \n",
       "22221                              azithromycin  Intervention         0   \n",
       "22232                        hydroxychloroquine  Intervention         0   \n",
       "...                                         ...           ...       ...   \n",
       "117736                                   severe  Intervention         0   \n",
       "117737                               non-severe  Intervention         0   \n",
       "120340                              combination  Intervention         0   \n",
       "120341            low molecular weight heparins  Intervention         0   \n",
       "120342                    ritonavir/lopinavir .  Intervention         0   \n",
       "120343                                 analysed  Intervention         0   \n",
       "120348                              tocilizumab  Intervention         0   \n",
       "120349                                corticoid  Intervention         0   \n",
       "120350                              tocilizumab  Intervention         0   \n",
       "120351                                corticoid  Intervention         0   \n",
       "120354                   in-hospital treatments  Intervention         0   \n",
       "120367                 therapeutic alternatives  Intervention         0   \n",
       "121020                    pre-existing diabetes  Intervention         0   \n",
       "121034                                 diabetes  Intervention         0   \n",
       "121042                                 diabetes  Intervention         0   \n",
       "121065                       hydroxychloroquine  Intervention         0   \n",
       "121066                            ) in hospital  Intervention         0   \n",
       "121080                              both groups  Intervention         0   \n",
       "121084                          LPV/RTV group .  Intervention         0   \n",
       "121087                       hydroxychloroquine  Intervention         0   \n",
       "121088                     LPV/RTV but patients  Intervention         0   \n",
       "121089                     showed a numerically  Intervention         0   \n",
       "121092                   LPV/RTV despite having  Intervention         0   \n",
       "121093                       hydroxychloroquine  Intervention         0   \n",
       "121094            lopinavir/ritonavir ( LPV/RTV  Intervention         0   \n",
       "121097                              if they had  Intervention         0   \n",
       "121439                       hydroxychloroquine  Intervention         0   \n",
       "121444                       hydroxychloroquine  Intervention         0   \n",
       "121449  hydroxychloroquine plasma concentration  Intervention         0   \n",
       "121452  hydroxychloroquine plasma concentration  Intervention         0   \n",
       "\n",
       "        start                                           sentence subtag  \\\n",
       "10944      15  % ] were men ) , of whom 115 ( 31.8 % ) were t...   None   \n",
       "10949       7  The percentage of patients with hypertension t...   None   \n",
       "10961      11  Similar findings were observed when data were ...   None   \n",
       "10962      15  Similar findings were observed when data were ...   None   \n",
       "10963      13  Conclusions and Relevance : This study provide...   None   \n",
       "10970       7  Objective : To investigate the association bet...   None   \n",
       "10978      21  The percentage of patients with hypertension t...   None   \n",
       "18980       0  Dyspnea was also independently associated with...   None   \n",
       "19011       1  Higher SpO2 levels after oxygen supplementatio...   None   \n",
       "19012       4  Higher SpO2 levels after oxygen supplementatio...   None   \n",
       "22060       5  The single cut-off point and high level of cTn...   None   \n",
       "22173       0  azithromycin , or both were more likely than t...   None   \n",
       "22175      11  azithromycin , or both were more likely than t...   None   \n",
       "22186       7  The probability of death for patients receivin...   None   \n",
       "22188      28  The probability of death for patients receivin...   None   \n",
       "22191      17  54/271 ( 19.9 % [ 95 % CI , 15.2 % -24.7 % ] )...   None   \n",
       "22194       6  -14.0 % ] ) , and neither drug , 28/221 ( 12.7...   None   \n",
       "22197      11  In adjusted Cox proportional hazards models , ...   None   \n",
       "22200      24  In adjusted Cox proportional hazards models , ...   None   \n",
       "22202      10  1.35 [ 95 % CI , 0.76-2.40 ] ) , hydroxychloro...   None   \n",
       "22204      26  1.35 [ 95 % CI , 0.76-2.40 ] ) , hydroxychloro...   None   \n",
       "22205       8  In logistic models , compared with patients re...   None   \n",
       "22208      19  In logistic models , compared with patients re...   None   \n",
       "22209       8  CI , 1.12-4.05 ] ) , but not hydroxychloroquin...   None   \n",
       "22210      24  CI , 1.12-4.05 ] ) , but not hydroxychloroquin...   None   \n",
       "22215      16  Conclusions and Relevance : Among patients hos...   None   \n",
       "22216      18  Conclusions and Relevance : Among patients hos...   None   \n",
       "22217      25  Conclusions and Relevance : Among patients hos...   None   \n",
       "22221      14  Objective : To describe the association betwee...   None   \n",
       "22232       5  Exposures : Receipt of both hydroxychloroquine...   None   \n",
       "...       ...                                                ...    ...   \n",
       "117736      8  No differences were observed of antibody level...   None   \n",
       "117737     10  No differences were observed of antibody level...   None   \n",
       "120340      6  RESULTS : The most frequently used combination...   None   \n",
       "120341     10  RESULTS : The most frequently used combination...   None   \n",
       "120342     18  RESULTS : The most frequently used combination...   None   \n",
       "120343      3  None of the analysed treatments showed indepen...   None   \n",
       "120348     11  The drugs that showed a greater inverse associ...   None   \n",
       "120349     13  The drugs that showed a greater inverse associ...   None   \n",
       "120350     16  It seems necessary to design randomized contro...   None   \n",
       "120351     18  It seems necessary to design randomized contro...   None   \n",
       "120354     16  The aim of this study was to assess the patter...   None   \n",
       "120367      7  To estimate the associations between the diffe...   None   \n",
       "121020     13  PURPOSE : The purpose of this study was to eva...   None   \n",
       "121034      8  CONCLUSION : In this retrospective single-cent...   None   \n",
       "121042     10  Multivariable logistic regression was performe...   None   \n",
       "121065      6  There was no significant difference ( HCQ vs. ...   None   \n",
       "121066      9  There was no significant difference ( HCQ vs. ...   None   \n",
       "121080     15  A PCR negativity from nasopharyngeal swabs was...   None   \n",
       "121084     13  Side effects led to treatment discontinuation ...   None   \n",
       "121087     15  CONCLUSION : No statistically significant diff...   None   \n",
       "121088     17  CONCLUSION : No statistically significant diff...   None   \n",
       "121089     24  CONCLUSION : No statistically significant diff...   None   \n",
       "121092     16  Additionally , in comparison to other studies ...   None   \n",
       "121093      5  To date no trial comparing hydroxychloroquine ...   None   \n",
       "121094     10  To date no trial comparing hydroxychloroquine ...   None   \n",
       "121097     23  METHODS : Hospitalized patients > =18 years ol...   None   \n",
       "121439      4  These findings indicate that hydroxychloroquin...   None   \n",
       "121444     12  The primary objective of this study was to ass...   None   \n",
       "121449      8  The study compared 17 patients in whom the hyd...   None   \n",
       "121452      5  No association was found between hydroxychloro...   None   \n",
       "\n",
       "            section      pmid  \n",
       "10944       METHODS  32324209  \n",
       "10949       METHODS  32324209  \n",
       "10961       METHODS  32324209  \n",
       "10962       METHODS  32324209  \n",
       "10963       METHODS  32324209  \n",
       "10970       METHODS  32324209  \n",
       "10978       METHODS  32324209  \n",
       "18980       METHODS  32376101  \n",
       "19011       RESULTS  32376101  \n",
       "19012       RESULTS  32376101  \n",
       "22060       RESULTS  32391877  \n",
       "22173       METHODS  32392282  \n",
       "22175       METHODS  32392282  \n",
       "22186       METHODS  32392282  \n",
       "22188       METHODS  32392282  \n",
       "22191       METHODS  32392282  \n",
       "22194       METHODS  32392282  \n",
       "22197       METHODS  32392282  \n",
       "22200       METHODS  32392282  \n",
       "22202       METHODS  32392282  \n",
       "22204       METHODS  32392282  \n",
       "22205       METHODS  32392282  \n",
       "22208       METHODS  32392282  \n",
       "22209       METHODS  32392282  \n",
       "22210       METHODS  32392282  \n",
       "22215       METHODS  32392282  \n",
       "22216       METHODS  32392282  \n",
       "22217       METHODS  32392282  \n",
       "22221       METHODS  32392282  \n",
       "22232       METHODS  32392282  \n",
       "...             ...       ...  \n",
       "117736      METHODS  32766541  \n",
       "117737      METHODS  32766541  \n",
       "120340   BACKGROUND  32773165  \n",
       "120341   BACKGROUND  32773165  \n",
       "120342   BACKGROUND  32773165  \n",
       "120343    OBJECTIVE  32773165  \n",
       "120348    OBJECTIVE  32773165  \n",
       "120349    OBJECTIVE  32773165  \n",
       "120350      METHODS  32773165  \n",
       "120351      METHODS  32773165  \n",
       "120354      METHODS  32773165  \n",
       "120367  CONCLUSIONS  32773165  \n",
       "121020        TITLE  32776197  \n",
       "121034      METHODS  32776197  \n",
       "121042      RESULTS  32776197  \n",
       "121065      METHODS  32776298  \n",
       "121066      METHODS  32776298  \n",
       "121080      METHODS  32776298  \n",
       "121084      METHODS  32776298  \n",
       "121087      METHODS  32776298  \n",
       "121088      METHODS  32776298  \n",
       "121089      METHODS  32776298  \n",
       "121092      RESULTS  32776298  \n",
       "121093      RESULTS  32776298  \n",
       "121094      RESULTS  32776298  \n",
       "121097      RESULTS  32776298  \n",
       "121439   BACKGROUND  32777263  \n",
       "121444      METHODS  32777263  \n",
       "121449      METHODS  32777263  \n",
       "121452      RESULTS  32777263  \n",
       "\n",
       "[365 rows x 8 columns]"
      ]
     },
     "execution_count": 243,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mort_pmids = np.unique(ent_df[(ent_df.text == \"in-hospital mortality\")&(ent_df.type == \"Outcome\")].pmid.values)\n",
    "ent_df[(ent_df.pmid.isin(mort_pmids))&(ent_df.type == \"Intervention\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['For cases of severe illness , early and also short periods of moderate glucocorticoid was supported .',\n",
       "       'According to the relevant diagnostic criteria , the patients were divided into three groups : mild ( 15 cases ) , severe ( 9 cases ) and critical ( 5',\n",
       "       'Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality .',\n",
       "       'Compared to the mild cases , the severe ones had lower lymphocyte counts and higher plasma levels of Pt , APTT , d-dimer , lactate dehydrogenase , PCT , ALB',\n",
       "       'Acute respiratory distress syndrome ( ARDS ) was the most severe pulmonary complication that caused high mortality rate .',\n",
       "       'Among them , two common and one severe patient were recovered and discharged in 10 days after treatment .',\n",
       "       'The symptoms in neonates were milder and outcomes were less severe compared to adults .',\n",
       "       'subjects , 2 with light , common or severe subjects , 1 with light and common subjects , 1 with common or severe subjects , 3 with severe subjects ,',\n",
       "       'them became severe .',\n",
       "       'Preliminary evidence suggests children are just as likely as adults to become infected with SARS-CoV-2 but are less likely to be symptomatic or develop severe symptoms .',\n",
       "       'With a median ( IQR ) follow-up time of 24.0 ( 17.5-30.0 ) days , progression occurred in 19.6 % moderate , 27.8 % severe and 66.7 % critical COVID-19',\n",
       "       'the management of severely ill patients with COVID-19 who develop acute respiratory and cardiac compromise refractory to conventional therapy .',\n",
       "       'In particular , all 8 of the DIP-treated severely ill patients showed remarkable improvement : 7 patients ( 87.5 % ) achieved clinical cure and were discharged from the hospitals',\n",
       "       'SARS-CoV-2-positive patients were classified as having mild ( n = 30 ) , severe ( n = 20 ) , and extremely severe ( n = 15 ) illness .',\n",
       "       'MAIN RESULTS : We identified 33 studies reporting 385 pregnant women with COVID-19 infection : 368 ( 95.6 % ) mild ; 14 ( 3.6 % ) severe ; and',\n",
       "       'Infants and young children had relatively more severe illness than older children .',\n",
       "       'Disease severity and clinical course characteristics of the patients and influencing factors of severe illness were analyzed in our study .',\n",
       "       'Methods : A retrospective case analysis of effectiveness and safety of aliskiren treatment to lower blood pressure in three severe and one critically ill patients of COVID-19 with hypertension .',\n",
       "       'Three cases were confirmed by 2019-nCoV nucleic acid and antibody detection ( severe type ) , and one with cardiac insufficiency was clinically determined ( critically ill type ) .',\n",
       "       'Compared with non-severely ill patients , severely ill patients were older ( mean , years , 52.8 vs. 45.3 , p < 0.01 ) , had a higher proportion of',\n",
       "       'Of the 43 severely ill patients , 6 ( 14 % ) received high-flow nasal cannula oxygen therapy , and 1 ( 2.3 % ) received invasive mechanical ventilation .',\n",
       "       'Outcomes of severely ill patients and non-severely ill patients were compared .',\n",
       "       'All patients were divided into severe ( 69 ) and non-severe group ( 135 ) .',\n",
       "       'In this retrospective study , we evaluated the levels of a series of serum biomarkers in coronavirus disease 2019 ( COVID-19 ) patients ( mild : 131 ; severe :',\n",
       "       'The differences in the hemocyte counts and dynamic profiles in patients with severe and non-severe COVID-19 were compared .',\n",
       "       '( 24.6 % ) had severe illness .',\n",
       "       'Forty-eight cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill , 25 severe , and 14 moderate patients were measured and analyzed in combination with clinical',\n",
       "       'shown to be highly associated with disease severity during disease progression , were remarkably higher in critically ill patients , followed by severe and then the moderate patients .',\n",
       "       'applied in severely ill patients to reduce pneumonia related mortality .',\n",
       "       'The included patients were classified into mild ( n = 168 ) , severe ( n = 169 ) and critical groups ( n = 52 ) .',\n",
       "       'applied for prophylaxis , for early phases of illness , and for severe illness .',\n",
       "       'Only one of the most severely ill patients scored > = 2 on the quick Sepsis-related Organ Failure Assessment ( qSOFA ) on admission .',\n",
       "       'Hydroxychloroquine-treated patients were more severely ill at baseline than those who did not receive hydroxychloroquine ( median ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen',\n",
       "       'Severe illness was associated with lower lymphocyte and higher leukocyte counts .',\n",
       "       '23 ( 11.4 % ) patients had severe illness .',\n",
       "       'This study aimed to describe the clinical characteristics of COVID-19 and identify the risk factors for severe illness of COVID-19 in Jiangsu province , China .',\n",
       "       'Clinical findings of COVID-19 patients were described and risk factors for severe illness of COVID-19 were analyzed .',\n",
       "       'Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications , with frequent fatal issues , occur in others .',\n",
       "       'presented with more severe forms ( higher level of oxygen therapy at 13 L/min vs 6 L/min , P < 0.001 ) , and had poorer biological findings ( severe',\n",
       "       'severe illness and of course before full-blown ARDS ( Acute Respiratory Distress Syndrome ) .',\n",
       "       'Of 64 pregnant women hospitalized with COVID-19 , 44 ( 69 % ) had severe and 20 ( 31 % ) critical disease .',\n",
       "       'The median duration of hospital stay was 6 days ( 6 days for severe , 10.5 days for critical , p=0.01 ) .',\n",
       "       'Thirty-two ( 50 % ) women in this cohort delivered during their COVID-19 hospitalization ( 34 % of severe and 85 % of critical women ) .',\n",
       "       '6 severe versus 12 critical ) .',\n",
       "       'For cases of severe illness , early and also short period of moderate glucocorticoid was supported .',\n",
       "       'RESULTS : One patient in HCQ group developed to severe during the treatment .',\n",
       "       'Conclusions and Relevance : This early report describes the burden of COVID-19 infection in North American PICUs and confirms that severe illness in children is significant but far less frequent',\n",
       "       'RESULTS : Patients with cardiovascular disease were at greater risk of developing COVID-19 , especially in its severe form .',\n",
       "       'moderately ill , severely ill , and critically ill , respectively .',\n",
       "       'Studies were divided into 2 separate cohorts for analysis : severity ( severe vs nonsevere ) and mortality ( nonsurvivors vs survivors ) .',\n",
       "       'A higher proportion of newborns was severely ill ( 12 % ) and dyspnea was the most common reported sign ( 40 % ) .',\n",
       "       'The resultant cytokine storm is responsible for the severe lung injury leading to acute respiratory distress syndrome seen in COVID 19 patients .',\n",
       "       'However , lymphopenia was more severe in males than females and levels of tumor necrosis factor alpha were reduced significantly in critical cases than severe and mild cases .',\n",
       "       'Severity of disease : 5.3 % light and common type , 17.6 % severe and critically ill and 59.6 % with no restricted classification .',\n",
       "       'METHODS : Sixty-nine patients with COVID-19 were classified into severe and nonsevere groups to analyze their clinical and laboratory characteristics .',\n",
       "       '; severe : 167 ( 138 , 197 ) ; critical : 125 ( 95 , 162 ) ; P < .05 ) across all three groups .',\n",
       "       'As recently reported , the cumulative risk of the composite end-point was 3.6 % in all COVID-19 patients , and the cumulative risk was 20.6 % for severe illness [',\n",
       "       'care for severely ill COVID-19 patients , including stratification , isolation , and affordable diagnostic approaches and supportive care measures .',\n",
       "       'Current evidence suggests an important role of interleukin-6 ( IL-6 ) pathway in SARS-CoV-2-related cytokine release storm in severely ill COVID-19 patients .',\n",
       "       'Patients with comorbidities are more likely to develop severe illness .',\n",
       "       'Three patients with comorbidities such as hypertension , liver diseases or diabetes developed severe illness .',\n",
       "       'High C-reactive protein levels and elevations of both ALT and AST were observed in 3 severely ill patients on admission .',\n",
       "       'Patients were classified into four groups , mild , moderate , severe and critically ill .',\n",
       "       'Thirty percent of our patients had severe or critically ill disease , but only 20 % of severe and 33 % of critically ill patients had been to Wuhan .',\n",
       "       'Conclusions Dynamic changes in vital hematological parameters from severe and non-severe patients had been characterized in the course of hospitalization .',\n",
       "       'We have measured Hb O2 affinity curves from severely ill COVID-19 patients and , in comparison to age- and sex-matched controls , find no evidence for a shift in O2',\n",
       "       'Early reports suggest a high incidence of VTE in hospitalized COVID-19 patients , particularly those with severe illness , that is similar to the high VTE rates observed in patients',\n",
       "       'Receiver operating characteristic analysis distinguished severe and nonsevere patients according to KL-6 serum levels and the best cut-off value was 406.5 U/mL .',\n",
       "       'severe illness .',\n",
       "       'ALT was between two and five times ULN , and severe if ALT was > five times ULN .',\n",
       "       'Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness .',\n",
       "       '42 consecutive pregnancies were recruited and classified into two groups : severe and nonsevere COVID-19 , according to the occurrence of severe pneumonia .',\n",
       "       'COVID-19 is especially severe for elderly subjects with cardiometabolic and respiratory comorbidities .',\n",
       "       'A higher frequency seems to be present in severely ill patients , in particular those admitted to intensive care units .',\n",
       "       'The trial included 103 participants with laboratory-confirmed COVID-19 that was severe ( respiratory distress and/or hypoxemia ) or life-threatening ( shock , organ failure , or requiring mechanical ventilation )',\n",
       "       'Therefore , we compared cell-mediated immune ( CMI ) responses between severe and mild COVID-19 cases .',\n",
       "       'Those with concomitant infections had more severe illness .',\n",
       "       'CONCLUSION : Together , our data suggest that early intervention to increase expression of CCL5 may prevent patients from developing severe illness .',\n",
       "       'The author mentioned that COVID-19 appeared to be milder in children than in adults but said there was a knowledge gap about antiviral treatment in severely ill patients .',\n",
       "       'A total of 54 patients were enrolled and divided into three groups , among which 34 were common , 14 were severe , and 6 were critical .',\n",
       "       'Peripheral blood from 18 SARS-CoV-2-infected patients , 9 with severe and 9 with mild COVID-19 disease , was obtained at admission and analyzed for T-cell activation profile , myeloid-derived suppressor',\n",
       "       'In four severe and in four mild patients , a longitudinal analysis was performed daily from the day of admission to the early convalescent phase .',\n",
       "       'Globally , 14 patients ( 20.3 % ) presented a mild , 30 ( 43.5 % ) a severe and 25 ( 36.2 % ) a critical COVID-19 disease .',\n",
       "       '21 ( 16.0 % ) severely ill patients and 5 ( 3.8 % ) individuals with life-threatening conditions .',\n",
       "       'The majority ( 97.8 % ) of infected children were not severe , and 24 ( 13.2 % ) of them had asymptomatic infections .',\n",
       "       'Patients with severe illness are found to have a higher cardio- cerebrovascular comorbidity .',\n",
       "       'Systemic immune over activation due to SARS-CoV-2 infection causes the cytokine storm , which is especially noteworthy in severely ill patients with COVID-19 .',\n",
       "       ', 78 ( 11.9 % ) , and 276 ( 42.1 % ) of the 655 patients , respectively , were significantly enriched among patients classified as severe .',\n",
       "       'Severe morbidity and mortality among women with MERS-CoV , SARS-CoV , or SARS-CoV-2 infection in pregnancy and adverse pregnancy outcomes , including pregnancy loss , preterm delivery , and laboratory',\n",
       "       'The clinical presentations were not as severe as the signs observed in the computed tomography ( CT ) images , and the recovery of lesions in lobules lagged behind that',\n",
       "       'SARS was characterized by severe lung injury due to virus-induced cytopathic effects and dysregulated hyperinflammatory state .',\n",
       "       'The incidences of AKI were compared between severe versus non-severe patients and survivors versus non-survivors .',\n",
       "       'Throughout the delivery hospitalization , 26.5 % of women met World Health Organization criteria for mild COVID-19 , 26.1 % for severe , and 5 % for critical .',\n",
       "       'Cesarean birth was the mode of delivery for 52.4 % of women with severe and 91.7 % with critical COVID-19 .',\n",
       "       'The results show that 27 ( 33.8 % ) patients had severe illness .',\n",
       "       'Treatment recommendations address 2 phases of hospitalization : when patients are critically ill and admitted to the intensive care unit , and when patients are severely ill and admitted to',\n",
       "       'Epidemiology studies found males although only slightly more likely to be infected than females account for the majority of the severely ill and fatality , which also bias for people',\n",
       "       'In conclusion , intensification of heparin treatment should be considered in the context of COVID-19 on the basis of clinical and biological criteria of severity , especially in severely ill',\n",
       "       'COVID-19 was severe in patients with lung cancer ( 62 % hospitalized , 25 % died ) .',\n",
       "       'Of the 54 patients ( 56.1 +- 13.5 years old , 66.7 % male ) with COVID-19 , 39 were diagnosed as severe and 15 as critical cases .',\n",
       "       'present a Perspective on diverse immunotherapeutic approaches based on the neutralization of inflammatory cytokines , immunomodulation , and passive viral neutralization for treating severely ill COVID-19 patients .',\n",
       "       'In addition , microcomputed tomographic imaging revealed severe lung injury that shared characteristics with SARS-CoV-2-infected human lung , including severe , bilateral , peripherally distributed , multilobular ground glass opacity',\n",
       "       'Hypertension was more prevalent in severe [ 47.65 % ( 95 % CI : 35.04 % , 60.26 % ) ] and fatal [ 47.90 % ( 95 % CI',\n",
       "       'A difference in C-reactive protein levels between severe and critical groups was also found ( P < 0.05 ) .',\n",
       "       'Results : A total of 114 COVID-19 patients ( 99 mild , 4 severe , 11 critical ) of which 56 ( 56/114 ; 49.1 % ) were male ,',\n",
       "       'Interpretation : This is the first systematic review exploring the risk factors for severe illness in COVID-19 patients .',\n",
       "       'The typical CT imaging features were as follows : the ordinary type mainly showed the single or multiple ground glass shadows on the chest image ; the severe type mainly',\n",
       "       'The patients were divided into mild , ordinary , severe and critical types .',\n",
       "       '23 % , moderate 38 % , extensive 22 % , and severe 7 % ) .',\n",
       "       'A total of 185 patients were included , 27 ( 14.59 % ) of whom were severely ill at the time of discharge and three ( 1.6 % ) of',\n",
       "       'In our view , targeting host-mediated immunopathology holds promise to alleviate progressive pathologic complications of ARDS and reduce morbidities and mortalities in severely ill patients with COVID-19 .',\n",
       "       \"Methods : We assembled a retrospective cohort of 80 patients ( including 56 mild and 24 severe ) with COVID-19 infection treated at Beijing You'an Hospital .\",\n",
       "       'The production and sialylation of AAT increased in COVID-19 , but this antiinflammatory response was overwhelmed in severe illness , with the IL-6 : AAT ratio markedly higher in patients',\n",
       "       'Secondary Endpoints : The patients are classified according to their oxygen levels as mild , moderate and severe and randomized according to their classification to the intervention and control in',\n",
       "       'This study aimed to determine the differences between laboratory parameters in ( 1 ) COVID-19 versus non-COVID-19 pneumonia , and ( 2 ) severe versus non-severe COVID-19 cases .',\n",
       "       'Severe Covid-19 occurs in the presence of impaired glucose metabolism in patients , including those with DM , PreDM and obesity .',\n",
       "       'The proportions of third-generation patients developing severe illness ( 72.7 % vs. 32.5 % and 27.3 % , p < 0.001 ) , critical illness ( 38.6 % vs. 10.8',\n",
       "       'Literature and experience from healthcare teams in the midst of the pandemic suggest that any COVID-19 patients with respiratory compromise severe enough to warrant admission should be considered for proning',\n",
       "       'Overall , 13.0 % ( 954 of 7,341 ) of the cases were severe .',\n",
       "       'Severe COVID-19 occurred despite suppressive antiretroviral therapy in this cohort .',\n",
       "       'Patients over the age of 60 were the ones having severe illness and more complications ( p < 0.05 ) .',\n",
       "       'severe and have a worse outcome than those without ( OR=2.31 , 95 % CI [ 1.3-4.12 ] ) .',\n",
       "       'Lymphopenia is severe and constant , with a nadir on day 2 of ICU stay ( median 0.555 109/L ; interquartile range ( IQR ) 0.450 109/L ) ; all',\n",
       "       'A total of 48 cases of COVID-19 were collected , of which 1 was mild , 38 were moderate , and 9 were severe .',\n",
       "       'seen in other severe pathogenic infections .',\n",
       "       'The severe and critically severe groups had elevated levels of white blood cells ( WBC ) , neutrophils , platelets , C-reaction protein ( CRP ) , lymphocyte ratio (',\n",
       "       'We conclude DKA is common and severe in individuals hospitalised with COVID-19 .',\n",
       "       ') patients belonged to the stable group , another 10 patients were severe before admission .',\n",
       "       'The differences between moderate ( 29.00 [ 25.75-37.50 ] ) and severe ( 43.00 [ 38.75-47.25 ] ) ( p = 0.022 ) or between moderate and critical ( 47.50',\n",
       "       'The cohort included 400 ( 66.89 % ) moderate cases , 85 ( 14.21 % ) severe and 113 ( 18.90 % ) critical cases , of whom 79 died',\n",
       "       'The degree of severity of COVID-19 patients ( severe vs. non-severe ) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia .',\n",
       "       'Two groups of patients with RT-PCR-confirmed COVID-19 were enrolled in this study : 12 severely ill patients in intensive care units who needed mechanical ventilation and 11 mildly ill patients',\n",
       "       'Results showed that most of the severely ill patients had viral shedding in a variety of tissues for 20-40 days after onset of disease ( 8/12 , 66.7 % )',\n",
       "       'Twenty-seven patients ( 36.5 % ) were severe and 10 patients ( 13.5 % ) died .',\n",
       "       'All patients had suffered from severe ( 5/9 ) or moderate ( 4/9 ) acute respiratory distress syndrome , requiring prolonged stay in the intensive care unit .',\n",
       "       'All patients were local residents of Wuhan , and a large proportion of them were diagnosed with severe illness when admitted .',\n",
       "       'Meanwhile , we monitored the serum lipid profile , COVID-19 nucleic acid and chest CT scan of a severe patient from the early stage of infection to the recovery period',\n",
       "       'Obesity is an independent risk factor for severe illness in COVID-19 .',\n",
       "       'Random effects meta-analysis was done to estimate standard mean difference ( SMD ) of NLR and PLR values with 95 % confidence interval ( CI ) between severe and non-severe',\n",
       "       'Nineteen studies reported NLR values , while five studies reported PLR values between severe and non-severe COVID-19 patients .',\n",
       "       'A total of 76 patients developed liver injury ( mild , 40.5 % ; moderate , 15.3 % ; severe , 2.3 % ) with a median occurrence time of',\n",
       "       'of severe illness than ARB users .',\n",
       "       'significantly higher than in those with severe ( 20 [ 14 % ] of 145 ) or moderate ( nine [ 6 % ] of 149 ) disease ( p',\n",
       "       'Elder age , increased number of affected lobes , higher levels of serum CRP , chest tightness/dyspnea , and smoking history were risk factors for mortality of severe COVID-19 patients',\n",
       "       'According to the disease severity , the patients were categorized as three groups ( moderate : 85 , severe : 54 , and critical : 20 ) .',\n",
       "       'Then , patients were divided into two groups : nonsevere ( moderate ) and severe ( severe and critical ) .',\n",
       "       'Severe bleeding events were described in severe ARDS patients requiring ECMO in large cohorts [ 2 ] .',\n",
       "       'In addition , CD3+ CD8+ T lymphocytes , CD16+ CD56+ NK cells , and complement C1q in severely ill patients decreased more significantly .',\n",
       "       'The mortality rate of severely ill patients in the early stage is 32.5 % .',\n",
       "       'This study analyzed clinical and biochemical parameters between mild and severe patients , helping to identify severe or critical patients early .',\n",
       "       'Results : Sixty studies comparing 5487 subjects with severe and 9670 subjects with mild COVID-19 documented higher PT ( SMD : 0.41 ; 95 % CI : 0.21 , 0.60',\n",
       "       'Patients aged under 18 years had higher re-positive rates than average , and none of the severely ill patients re-tested positive .',\n",
       "       'Headache , dizziness , taste and smell dysfunctions , and impaired consciousness were the most frequently described neurological symptoms , the latter more often among patients with a severe or',\n",
       "       'In vitro , ViroSAL inhibited the enveloped viruses Epstein-Barr , measles , herpes simplex , Zika and orf parapoxvirus , together with Ebola , Lassa , vesicular stomatitis and severe',\n",
       "       'Significant differences were observed when comparing severe and non-severe patients .',\n",
       "       'Studies were included in our meta-analysis if it was published in peer-reviewed journals and recorded patient characteristics of severe versus nonsevere or survivor versus nonsurvivor in coronavirus disease 2019 infection',\n",
       "       'Further analysis showed that decreases in lymphocytes , total proteins , and SOD and elevations in neutrophils , FDP , CRP , and ESR were more common in severe than',\n",
       "       'Six ( 14.6 % ) patients died ( severe : 2 , critical : 4 ) ; high creatinine with low lymphocyte count was the biggest challenge of immunosuppression management',\n",
       "       'Patients were classified into three catalogs according to severity of pneumonia : 17 ( 41.5 % ) were mild , 15 ( 36.6 % ) severe , and 9 (',\n",
       "       'In this comparative analysis , by day 14 , remdesivir was associated with significantly greater recovery and 62 % reduced odds of death versus standard-of-care treatment in patients with severe',\n",
       "       'We also analyzed whether the use of these drugs affects the risk of SARS-CoV-2 infection , severe illness or mortality based on recent studies .',\n",
       "       'Previously , there were two outbreaks of severe coronavirus caused by different coronaviruses worldwide , namely Severe Acute Respiratory Syndrome Coronavirus ( SARS-CoV ) and the Middle East Respiratory Syndrome',\n",
       "       'Median IgG and IgM levels in acute and convalescent-phase sera ( within 35 days ) for all included patients were calculated and compared between severe and non-severe patients .',\n",
       "       'Particularly , immunomodulatory mechanisms employed by the placenta may mitigate violent immune response , maybe soften cytokine storm tightly associated with severely ill COVID-19 patients , possibly minimizing cell and',\n",
       "       '61.3 % were severe , and 38.7 % were mild .',\n",
       "       'The overall outcome was severe , with high frequencies of hospitalisation ( 69.8 % ) , respiratory support oxygen ( 55.7 % ) , non-invasive ventilation ( 20.9 % )',\n",
       "       'Secondary bacterial infection was detected in 41 % of critical cases , but none of the severe ones .',\n",
       "       'Disease course of the patients was grouped as severe or critical , according to their clinical , laboratory and radiologic evaluations .',\n",
       "       'Of the 891 cases , 582 were severe or critical , including 423 ( 73 % ) severe and 159 ( 27 % ) critical cases .',\n",
       "       'Of the 891 cases , 582 were severe or critical , including 423 ( 73 % ) severe and 159 ( 27 % ) critical cases .',\n",
       "       'in the management of severely ill COVID-19 patients .',\n",
       "       'severe illness .',\n",
       "       'Overweight and obesity were independent risk factors of severe illness in COVID-19 patients .',\n",
       "       'Two hundred and sixty-one patients ( 22 % ) developed a severe illness after admission .',\n",
       "       'sNox2-dp values were higher in Covid-19 patients versus controls and in severe versus non severe Covid-19 .',\n",
       "       'Their mean age was 47.8 years , 43 ( 67.2 % ) cases were non-severe , 21 ( 32.8 % ) were severe , and 2 patients ( 3.1 %',\n",
       "       'Patients with co-morbidities such as hypertension , cardiovascular disease , and diabetes mellitus ( DM ) seem to be more prone to severe symptoms and appear to have a higher',\n",
       "       'This review aims to assess the risk of drug-drug interactions in the severely ill COVID-19 patient .',\n",
       "       'Increases in the level of serum liver enzymes , D-dimer , cardiac troponin I , and creatinine have been observed in severely ill patients , indicating that multiple organ failure',\n",
       "       '% ) were severe or required ICU care .',\n",
       "       'During the follow-up , 30 % vs. 31.4 % in HBV group vs. non-HBV group progressed to severe COVID-19 ( p=0.97 ) .',\n",
       "       'CONCLUSIONS : Severe or critically ill patients with COVID-19 is about one-tenths of patients in Jiangsu .',\n",
       "       'There was a significant older age among severe ( 62.6 years old +-10.1SD ) than mild to moderate infection ( 55.5 +- 10.1 ) ( p 0.05 ) .',\n",
       "       'Importantly , three patients , one severe and two critical ill type , with increased D-dimer survived after anticoagulant therapy with continuous heparin infusion .',\n",
       "       'severe or progression toward severe COVID-19 .',\n",
       "       ', severe ( n = 7 ) , and critical ( n = 2 ) .',\n",
       "       'n = 18 ) , and continuously severe or critical ( n = 9 ) .',\n",
       "       'We then focused on investigating the differences in the epidemiological and laboratory indicators between remained stable cases and progressed to severe condition cases .',\n",
       "       'No differences were observed of antibody levels between severe and non-severe patients .',\n",
       "       'Younger infants and those with comorbidity were found to be at risk of severe illness .',\n",
       "       'Fifty-four PLWH developed COVID-19 with 14 severe ( 25.9 % ) and five critical cases ( 9.3 % ) , respectively .',\n",
       "       'n = 1 ) , severe ( n = 2 ) , and critical ( n = 1 ) involvement .',\n",
       "       'RESULTS : All 35 patients were diagnosed as having mild-to-moderate COVID-19 at admission , but the severity aggravated to severe in 8 patients ( 22.9 % ) in hospital .',\n",
       "       'Similar trends were observed comparing severe to non-severe groups .',\n",
       "       'In this study we examined hospitalized kidney transplant recipients with non-severe ( n = 21 ) and severe ( n =19 ) COVID-19 .'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent_df[(ent_df.text == \"severe\") & (ent_df.subtag == \"None\")].sentence.values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([{'Section': 'METHODS', 'text': 'Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals , especially in China .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Coronavirus is interspecies and can also be transmitted from man to man , with an incubation ranging from 1 to 14 days .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Human coronavirus infections can induce not only mild to severe respiratory diseases , but also inflammation , high fever , cough , acute respiratory tract infection and dysfunction of internal', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'organs that may lead to death .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Coronavirus infection ( regardless of the various types of corona virus ) is primarily attacked by immune cells including mast cells ( MCs ) , which are located in the', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Viral activate MCs release early inflammatory chemical copounds including histamine and protease ; while late activation provoke the generation of pro-inflammatory IL-1 family members including IL-1 , IL-6 and IL-33', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': '.', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Here , we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL-1 family members .', 'entities': {'entity_1': {'text': 'inflammation', 'class': 'Outcome', 'negation': 0, 'UMLS': '', 'start': 9}, 'entity_2': {'text': 'coronavirus', 'class': 'Participant', 'negation': 0, 'UMLS': '', 'start': 11}, 'attribute_1': {'text': 'inhibited', 'class': 'modifier', 'negation': 0, 'UMLS': '', 'start': 13}}, 'relations': {}}],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "file = \"32013309.json\"\n",
    "file_path = os.path.join(folder, file)\n",
    "temp = pd.read_json(file_path)\n",
    "    \n",
    "temp.sentences.values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('TITLE',\n",
       "  'Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.'),\n",
       " ('BACKGROUND',\n",
       "  'Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals , especially in China .'),\n",
       " ('RESULTS',\n",
       "  'Coronavirus is interspecies and can also be transmitted from man to man , with an incubation ranging from 1 to 14 days .'),\n",
       " ('RESULTS',\n",
       "  'Human coronavirus infections can induce not only mild to severe respiratory diseases , but also inflammation , high fever , cough , acute respiratory tract infection and dysfunction of internal organs that may lead to death .'),\n",
       " ('RESULTS',\n",
       "  'Coronavirus infection ( regardless of the various types of corona virus ) is primarily attacked by immune cells including mast cells ( MCs ) , which are located in the submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms .'),\n",
       " ('RESULTS',\n",
       "  'Viral activate MCs release early inflammatory chemical copounds including histamine and protease ; while late activation provoke the generation of pro-inflammatory IL - 1 family members including IL - 1 , IL - 6 and IL - 33 .'),\n",
       " ('CONCLUSIONS',\n",
       "  'Here , we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL - 1 family members .')]"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sections.get(\"32013309\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Send counters to pickle file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 222,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "ent_df = pd.read_csv(\"LitCovid_treatment_ents.csv\")\n",
    "p_count = Counter(ent_df[ent_df.type == \"Participant\"].text.values)\n",
    "i_count = Counter(ent_df[ent_df.type == \"Intervention\"].text.values)\n",
    "o_count = Counter(ent_df[ent_df.type == \"Outcome\"].text.values)\n",
    "\n",
    "counters = [p_count, i_count, o_count]\n",
    "c_names = [\"p_count\", \"i_count\", \"o_count\"]\n",
    "for i in range(len(counters)):\n",
    "    with open(\"Pickles/\" + c_names[i] + '.pickle', 'wb') as file:\n",
    "        pickle.dump(counters[i], file)\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('dead', 1689),\n",
       " ('covid-19', 1064),\n",
       " ('outcome', 358),\n",
       " ('severe covid-19', 335),\n",
       " ('safety', 246),\n",
       " ('D-dimer', 211),\n",
       " ('fever', 202),\n",
       " ('efficacy', 202),\n",
       " ('symptom', 199),\n",
       " ('comorbidity', 170),\n",
       " ('prognosi', 167),\n",
       " ('mortality rate', 152),\n",
       " ('IL-6', 152),\n",
       " ('cough', 144),\n",
       " ('severe', 142),\n",
       " ('clinical outcomes', 128),\n",
       " ('C-reactive protein', 128),\n",
       " ('mechanical ventilation', 114),\n",
       " ('disease severity', 107),\n",
       " ('complication', 104),\n",
       " ('treatment', 102),\n",
       " ('severity', 102),\n",
       " ('cytokine storm', 98),\n",
       " ('in-hospital mortality', 98),\n",
       " ('severity of COVID-19', 92),\n",
       " ('risk factors', 89),\n",
       " ('CRP', 87),\n",
       " ('lymphopenium', 81),\n",
       " ('odds ratio', 81),\n",
       " ('hospitalization', 79),\n",
       " ('dyspnea', 78),\n",
       " ('ACE2', 75),\n",
       " ('infection', 74),\n",
       " ('ICU admission', 72),\n",
       " ('lymphocyte count', 71),\n",
       " ('binding affinity', 70),\n",
       " ('effectivenes', 69),\n",
       " ('fatigue', 69),\n",
       " ('COVID-19 severity', 69),\n",
       " ('clinical symptoms', 67),\n",
       " ('clinical characteristics', 66),\n",
       " ('survival', 66),\n",
       " ('risk of death', 64),\n",
       " ('morbidity', 62),\n",
       " ('ferritin', 61),\n",
       " ('procalcitonin', 60),\n",
       " ('pneumonium', 58),\n",
       " ('TNF-alpha', 57),\n",
       " ('intubation', 56),\n",
       " ('IL-10', 56),\n",
       " ('interaction', 55),\n",
       " ('adverse events', 55),\n",
       " ('risk', 55),\n",
       " ('specificity', 55),\n",
       " ('acute respiratory distress syndrome', 54),\n",
       " ('diabetes', 54),\n",
       " ('lactate dehydrogenase', 53),\n",
       " ('lymphocyte', 53),\n",
       " ('ACE2 expression', 53),\n",
       " ('D-dimer levels', 53),\n",
       " ('ARD', 51),\n",
       " ('stability', 49),\n",
       " ('clinical course', 48),\n",
       " ('risk of mortality', 48),\n",
       " ('sensitivity', 48),\n",
       " ('disease progression', 48),\n",
       " ('inflammation', 47),\n",
       " ('diarrhea', 47),\n",
       " ('hypertension', 47),\n",
       " ('clinical manifestations', 46),\n",
       " ('effect', 46),\n",
       " ('AKI', 46),\n",
       " ('respiratory failure', 46),\n",
       " ('LDH', 45),\n",
       " ('in-hospital death', 45),\n",
       " ('hazard ratio', 44),\n",
       " ('viral load', 43),\n",
       " ('fibrinogen', 43),\n",
       " ('C-reactive protein ( CRP )', 42),\n",
       " ('laboratory findings', 41),\n",
       " ('shortness of breath', 40),\n",
       " ('immune response', 40),\n",
       " ('clinical outcome', 39),\n",
       " ('icu', 38),\n",
       " ('binding energy', 38),\n",
       " ('cytokine', 38),\n",
       " ('affinity', 37),\n",
       " ('IL-8', 37),\n",
       " ('progression', 37),\n",
       " ('invasive mechanical ventilation', 37),\n",
       " ('myocardial injury', 36),\n",
       " ('hospitalized', 35),\n",
       " ('antiviral activity', 35),\n",
       " ('Fever', 35),\n",
       " ('incidence', 35),\n",
       " ('headache', 34),\n",
       " ('fatality', 34),\n",
       " ('mortality rates', 34),\n",
       " ('heart failure', 34),\n",
       " ('albumin', 34)]"
      ]
     },
     "execution_count": 224,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "o_count.most_common(100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Building weighted graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 28%|█████████████████▊                                              | 33980/121669 [03:07<12:23, 117.86it/s]"
     ]
    }
   ],
   "source": [
    "from collections import Counter\n",
    "import itertools as it\n",
    "\n",
    "# get data and group\n",
    "ent_df = pd.read_csv(\"LitCovid_treatment_ents.csv\")\n",
    "g = ent_df.groupby([\"pmid\", \"type\"])\n",
    "\n",
    "#initialize variables\n",
    "groups = list(g.groups)\n",
    "types = [\"Participant\", \"Outcome\", \"Intervention\"]\n",
    "edge_weight = Counter()\n",
    "nodes = []\n",
    "\n",
    "for p in tqdm(ent_df.pmid.values):\n",
    "    temp = []\n",
    "    for tup in list(it.product([p], types)):\n",
    "        if tup in groups:\n",
    "            \n",
    "            #get pmid entities\n",
    "            grp = g.get_group(tup)\n",
    "            \n",
    "            #format appropriately\n",
    "            temp_nodes = [\"{} ({})\".format(t, tup[1][0]) for t in grp.text.values]\n",
    "            temp.append(temp_nodes)\n",
    "            nodes += temp_nodes\n",
    "        else:\n",
    "            temp.append([])\n",
    "            \n",
    "    #get edges\n",
    "    products = [list(it.product(temp[0], temp[1])), list(it.product(temp[0], temp[2])), list(it.product(temp[1], temp[2]))]\n",
    "    \n",
    "    #add edges to adj list\n",
    "    for prod in products:\n",
    "        if prod != []:\n",
    "            edge_weight.update(prod)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Pickles/\" + 'wb') as file:\n",
    "    pickle.dump(edge_weight, file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('edges.pickle', 'rb') as file:\n",
    "    edge_weight = pickle.load(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "from pyvis.network import Network\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "G = nx.Graph()\n",
    "for item in edge_weight.most_common(200):\n",
    "    G.add_edge(item[0][0], item[0][1], weight=item[1]*100)\n",
    "\n",
    "\n",
    "\n",
    "g = Network(height=800, width=800, notebook=True)\n",
    "g.barnes_hut()\n",
    "g.from_nx(G)\n",
    "g.show_buttons(filter_=['physics'])\n",
    "g.show(\"ex.html\")\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
